Abstract
Cancer patients frequently explore complementary and alternative medicine (CAM) modalities to alleviate symptoms related to disease and treatment. Patients are increasingly turning to botanical and herbal medicines to replace or supplement conventional treatments in order to provide relief.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Abe Y, Hashimoto S et al (1999) Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. Pharmacol Res 39(1):41–47
Aggarwal BB, Kumar A (2003) Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 23(1A):363–398
Bharti AC, Donato N et al (2003) Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood 101(3):1053–1062
Bharti AC, Shishodia S et al (2004a) Nuclear factor-kappaB and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis. Blood 103(8):3175–3184
Bharti AC, Takada Y et al (2004b) Curcumin (diferuloylmethane) inhibits receptor activator of NF-kappa B ligand-induced NF-kappa B activation in osteoclast precursors and suppresses osteoclastogenesis. J Immunol 172(10):5940–5947
Bishop FL, Prescott P (2010) Prevalence of complementary medicine use in pediatric cancer: a systematic review. Pediatrics 125(4):768–776
Block KI, Gyllenhaal C et al (2004) Safety and efficacy of herbal sedatives in cancer care. Integr Cancer Ther 3(2):128–148
Cheng AL, Hsu CH (2001) Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 21(4B):2895–2900
Dhillon N, Aggarwal BB et al (2008) Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res 14(14):4491–4499
Dorai T, Cao YC et al (2001) Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo. Prostate 47(4):293–303
Elam JL, Carpenter JS et al (2006) Methodological issues in the investigation of ginseng as an intervention for fatigue. Clin Nurse Spec 20(4):183–189
Ernst E, Pittler MH (2000) Efficacy of ginger for nausea and vomiting: a systematic review of randomized clinical trials. Br J Anaesth 84(3):367–371
Forester SC, Lambert JD (2011) The role of antioxidant versus pro-oxidant effects of green tea polyphenols in cancer prevention. Mol Nutr Food Res 55(6):844–854
Garami M, Schuler D et al (2004) Fermented wheat germ extract reduces chemotherapy-induced febrile neutropenia in pediatric cancer patients. J Pediatr Hematol Oncol 26(10):631–635
Goel A, Kunnumakkara AB et al (2008) Curcumin as “Curecumin”: from kitchen to clinic. Biochem Pharmacol 75(4):787–809
Karmakar S, Choudhury SR (2011) Molecular mechanisms of anti-cancer action of garlic compounds in neuroblastoma. Anticancer Agents Med Chem 11(4):398–407
Kim JY, Kwon O (2009) Garlic intake and cancer risk: an analysis using the Food and Drug Administration’s evidence-based review system for the scientific evaluation of health claims. Am J Clin Nutr 89(1):257–264
Korutla L, Kumar R (1994) Inhibitory effect of curcumin on epidermal growth factor receptor kinase activity in A431 cells. Biochim Biophys Acta 1224(3):597–600
Korutla L, Cheung JY et al (1995) Inhibition of ligand-induced activation of epidermal growth factor receptor tyrosine phosphorylation by curcumin. Carcinogenesis 16(8):1741–1745
Ladas EJ, Kroll DJ (2010) A randomized, controlled, double-blind, pilot study of milk thistle for the treatment of hepatotoxicity in childhood acute lymphoblastic leukemia (ALL). Cancer 116(2):506–513
Mansky PJ, Straus SE (2002) St. John’s Wort: more implications for cancer patients. J Natl Cancer Inst 94(16):1187–1188
Mansky PJ, Wallerstedt DB (2006) Complementary medicine in palliative care and cancer symptom management. Cancer J 12(5):425–431
Mathijssen RH, Verweij J et al (2002) Effects of St. John’s Wort on irinotecan metabolism. J Natl Cancer Inst 94(16):1247–1249
Mizutani Y, Nio Y, Yoshida O (1992) Effect of PSK and its subfractions on peripheral blood lymphocytes mediated cytotoxicity against urinary bladder tumor cells. J Urol 148(5):1571–1576
Mukhopadhyay A, Banerjee S et al (2002) Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation. Oncogene 21(57):8852–8861
Ng TB (1998) A review of research on the protein-bound polysaccharide (polysaccharopeptide, PSP) from the mushroom Coriolus versicolor (Basidiomycetes: Polyporaceae). Gen Pharmacol 30(1):1–4
Oba K, Teramukai S et al (2007) Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curative resections of gastric cancer. Cancer Immunol Immunother 56(6):905–911
Oberbaum M, Yaniv I et al (2001) A randomized, controlled clinical trial of the homeopathic medication TRAUMEEL S in the treatment of chemotherapy-induced stomatitis in children undergoing stem cell transplantation. Cancer 92(3):684–690
Piscitelli SC, Burstein AH et al (2000) Indinavir concentrations and St John’s wort. Lancet 355(9203):547–548
Plummer SM, Holloway KA et al (1999) Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex. Oncogene 18(44):6013–6020
Rao CV, Simi B et al (1993) Inhibition by dietary curcumin of azoxymethane-induced ornithine decarboxylase, tyrosine protein kinase, arachidonic acid metabolism and aberrant crypt foci formation in the rat colon. Carcinogenesis 14(11):2219–2225
Richardson MA, Sanders T et al (2000) Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 18(13):2505–2514
Sandur SK, Pandey MK et al (2007) Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. Carcinogenesis 28(8):1765–1773
Sharma RA, Euden SA et al (2004) Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res 10(20):6847–6854
Sharma RA, Steward WP et al (2007) Pharmacokinetics and pharmacodynamics of curcumin. Adv Exp Med Biol 595:453–470
Shishodia S, Chaturvedi MM et al (2007) Role of curcumin in cancer therapy. Curr Probl Cancer 31(4):243–305
Singh BN, Shankar S (2011) Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochem Pharmacol 82(12):1807–1821
Singh AK, Sidhu GS et al (1996) Curcumin inhibits the proliferation and cell cycle progression of human umbilical vein endothelial cell. Cancer Lett 107(1):109–115
Smith JE, Rowan NJ, Sullivan R (2002) Medicinal mushrooms: their therapeutic properties and current medical usage with special emphasis on cancer treatments. University of Strathclyde, Strathclyde, pp 1–256
Sontakke S, Thawani V et al (2003) Ginger as an antiemetic in nausea and vomiting induced by chemotherapy: a randomized, cross-over, double blind study. Indian J Pharmacol 35(1):32–36
Sparreboom A, Baker SD (2009) CAM: chemo interactions – what is known? In: Abrams D, Weil A (eds) Integrative oncology. Oxford University Press, New York
Sullivan R, Smith JE et al (2006) Medicinal mushrooms and cancer therapy: translating a traditional practice into western medicine. Perspect Biol Med 49(2):159–170
Taixiang W, Munro AJ et al (2005) Chinese medical herbs for chemotherapy side effects in colorectal cancer patients. Cochrane Database Syst Rev (1):CD004540
Tamayo C, Diamond S (2007) Review of clinical trials evaluating safety and efficacy of milk thistle (Silybum marianum [L.] Gaertn.). Integr Cancer Ther 6(2):146–157
Thaloor D, Singh AK et al (1998) Inhibition of angiogenic differentiation of human umbilical vein endothelial cells by curcumin. Cell Growth Differ 9(4):305–312
van Erp NP, Baker SD et al (2005) Effect of milk thistle (Silybum marianum) on the pharmacokinetics of irinotecan. Clin Cancer Res 11(21):7800–7806
Xu L, Lao LX et al (2007) Chinese herbal medicine for cancer pain. Integr Cancer Ther 6(3):208–234
Ying JZ et al (1987) Icons of medicinal fungi from China (trans: Xu YH). Science Press, Bei**g
Yodkeeree S, Chaiwangyen W (2008) Curcumin, demethoxycurcumin and bisdemethoxycurcumin differentially inhibit cancer cell invasion through the down-regulation of MMPs and uPA. J Nutr Biochem 20(2):87–95
Yuan JM, Sun C (2011) Tea and cancer prevention: epidemiological studies. Pharmacol Res 64(2):123–135
Zhang M, Liu X et al (2007) Chinese medicinal herbs to treat the side-effects of chemotherapy in breast cancer patients. Cochrane Database Syst Rev (2):CD004921
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Mansky, P.J. (2012). Botanicals in Pediatric Oncology and the Issue of Botanical/Drug Interactions. In: Längler, A., Mansky, P., Seifert, G. (eds) Integrative Pediatric Oncology. Pediatric Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-04201-0_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-04201-0_10
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-04200-3
Online ISBN: 978-3-642-04201-0
eBook Packages: MedicineMedicine (R0)